Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-17,414
Closed -$514K 91
2014
Q4
$514K Sell
17,414
-1,173
-6% -$33.6K 0.6% 51
2014
Q3
$522K Sell
18,587
-3,934
-17% -$110K 0.6% 49
2014
Q2
$634K Sell
22,521
-14,876
-40% -$424K 0.71% 42
2014
Q1
$1.14M Sell
37,397
-7,105
-16% -$212K 1.11% 28
2013
Q4
$1.29M Sell
44,502
-2,086
-4% -$60.7K 1.23% 23
2013
Q3
$1.27M Sell
46,588
-25,467
-35% -$693K 1.24% 21
2013
Q2
$1.92M Buy
+72,055
New +$1.99M 1.26% 21

Other funds holding PFE

Reliance Trust's PFE Position: Q1 2015 in Review

Reliance Trust sold out of Pfizer (PFE) in Q1 2015, closing a stake of 17,414 shares — an estimated $514K sold.

Reliance Trust first reported a position in PFE in Q2 2013 and held it in 7 quarters. The position peaked at $1.92M in Q2 2013. 1,877 funds tracked by Wall St. Rank hold PFE as of Q1 2015.

  • Reliance Trust reported no remaining Pfizer position as of Q1 2015 after selling out during the quarter.
  • Reliance Trust sold 17,414 Pfizer shares in Q1 2015, an estimated $514K.
  • Reliance Trust first reported a position in Pfizer in Q2 2013 and held it in 7 quarters.
  • Reliance Trust's Pfizer position peaked at $1.92M in Q2 2013.
  • 1,877 funds tracked by Wall St. Rank held Pfizer as of Q1 2015.

Based on Reliance Trust's 13F filing for Q1 2015, filed 24 Apr 2015.